Cleary Gottlieb has advised Viking Global Investors. Gibson Dunn has advised Damora Therapeutics. The acquisition of Damora Therapeutics Inc. by Galecto Inc. was completed alongside a...
Galecto Acquires Damora Therapeutics and Secures $285 Million PIPE Investment
Viking Global Investors Participates in Rockefeller Capital Management’s $6.6 Billion Recapitalization
Cleary Gottlieb has advised Viking Global Investors. Wachtell, Lipton, Rosen & Katz has advised Rockefeller Capital Management. Sullivan & Cromwell has advised the Rockefeller Family Trust....
Viking Global Investors Acquires Majority Stake in Callstack
Clifford Chance has advised Viking Global Investors. CMS has advised Callstack shareholders Anna Lankauf, Mike Grabowski, Piotr Karwatka, and Tomasz Karwatka. Viking Global Investors has acquired...
Viking Global Investors Acquires Majority Stake in Voyado
Clifford Chance and Vinge advised Viking Global Investors. Viking Global Investors has completed the acquisition of a majority stake in Voyado, a Stockholm-based customer experience platform...
Viking Invests $125 Million in ORIC Pharmaceuticals PIPE Financing
Cleary Gottlieb represented Viking Global Investors in the transaction. ORIC Pharmaceuticals Inc. (ORIC), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and...
Viking Global Investors’ Acquisition Of Minority Stake In Humaneva
Clifford Chance advised Viking Global Investors on the deal. Viking Global Investors (Viking), a global investment firm based in the United States, acquired a significant minority...
Viking’s $125 Million PIPE Investment in ORIC
Cleary Gottlieb represented Viking Global Investors in the transaction. Viking Global Investors (Viking) executed a PIPE investment in ORIC Pharmaceuticals, Inc. (ORIC), a clinical-stage biopharmaceutical company dedicated...
Viking Global Investors’ $200 Million PIPE Investment in Inhibrx
Cleary Gottlieb represented Viking Global Investors in the transaction. Viking Global Investors announced a PIPE investment in Inhibrx, Inc., a clinical-stage biopharmaceutical company dedicated to the...
Cazoo’s $630 Million Convertible Notes Offering
Freshfields advised Cazoo Group Ltd on the deal. Paul, Weiss, Rifkind, Wharton & Garrison advised funds affiliated with Viking Global Investors. Cazoo Group Ltd (“Cazoo”) offered...